US20050192374A1 - Dental resin composition, method of manufacture, and method of use thereof - Google Patents

Dental resin composition, method of manufacture, and method of use thereof Download PDF

Info

Publication number
US20050192374A1
US20050192374A1 US11/046,093 US4609305A US2005192374A1 US 20050192374 A1 US20050192374 A1 US 20050192374A1 US 4609305 A US4609305 A US 4609305A US 2005192374 A1 US2005192374 A1 US 2005192374A1
Authority
US
United States
Prior art keywords
hydroxy
meth
acrylate
alkyl
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US11/046,093
Other versions
US7700667B2 (en
Inventor
Weitao Jia
Shuhua Jin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pentron Clinical Technologies LLC
Original Assignee
Pentron Clinical Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentron Clinical Technologies LLC filed Critical Pentron Clinical Technologies LLC
Priority to US11/046,093 priority Critical patent/US7700667B2/en
Assigned to PENTRON CLINICAL TECHNOLOGIES, LLC reassignment PENTRON CLINICAL TECHNOLOGIES, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JIA, WEITAO, JIN, SHUHUA
Publication of US20050192374A1 publication Critical patent/US20050192374A1/en
Application granted granted Critical
Publication of US7700667B2 publication Critical patent/US7700667B2/en
Assigned to BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT reassignment BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KERR CORPORATION
Assigned to KERR CORPORATION reassignment KERR CORPORATION RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/50Preparations specially adapted for dental root treatment
    • A61K6/54Filling; Sealing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/30Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Definitions

  • This invention relates to dental resin compositions comprising polymerizable (meth)acrylate resins, their method of manufacture, and the use of such resins for restorative dentistry, including dental adhesives, dental cements, dental filling materials, root canal sealants, crown and bridge materials, and the like.
  • materials used for dental restorations have principally comprised acrylate or methacrylate resins.
  • Resinous materials of this type are disclosed, for example, in U.S. Pat. No. 3,066,112 to Bowen, No. 3,194,784 to Bowen, and No. 3,926,906 to Lee et al.
  • An especially important methacrylate monomer is the condensation product of bisphenol A and glycidyl methacrylate, 2,2′-bis[4-(3-methacryloxy-2-hydroxy propoxy)-phenyl]-propane (“BisGMA”).
  • BisGMA may be synthesized from the diglycidyl ether of bisphenol A and methacrylic acid (see, e.g., U.S. Pat. No. 3,066,112 to Bowen).
  • compositions are useful for a variety of dental treatments and restorative functions including crown and bridge materials, fillings, adhesives, sealants, luting agents or cements, denture base materials, orthodontic materials and sealants, and other dental restorative materials. Despite their suitability for their intended purposes, however, many of these materials have shrinkages of about two to about four percent by volume upon polymerization.
  • composition comprising a polymerizable (meth)acrylate of general structure I: wherein
  • a method of manufacturing a composition comprising a polymerizable (meth)acrylate comprises reacting a hydroxy-containing (meth)acrylate monomer of structure II: wherein
  • a method of making a dental restoration comprises applying to a site to be restored a composition comprising the above-described polymerizable (meth)acrylate of general structure I, and polymerizing the (meth)acrylate.
  • the FIGURE is a graph illustrating cure time after ageing of a composition in accordance with the present invention and a control.
  • the polymerizable (meth)acrylates described herein are useful as dental resins and possess improved properties over existing dental resins, and correspondingly enhance the properties of dental restorative materials prepared from such resins.
  • the polymerizable (meth)acrylates provide excellent bonding strength between a dental substrate (dentin, enamel, or other tooth structure) and the dental restorative material made from the polymerizable (meth)acrylate.
  • dental restorative materials prepared from the polymerizable (meth)acrylates exhibit reduced shrinkage upon polymerization to provide a better seal between the dental restoration and the repaired tooth.
  • an improved dental resin is of formula I:
  • n 0, 1, 2, or 3
  • q is 0 or 1
  • A is an anhydride group
  • a is 0 or 1.
  • the anhydride group (—C(O)—O—C(O)—) is linked via its two carbon atoms to two ortho carbons of the phenyl ring.
  • a is 0.
  • n is preferably 1 or 2.
  • R 1 , R 2 , R 3 , and R 4 are each independently hydrogen, hydroxy, C 1 -C 12 alkyl, C 1 -C 12 perhaloalkyl, C 1 -C 12 alkoxy, C 1 -C 12 perhaloalkoxy, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, (C 1 -C 6 alkyl)-O-(C 1 -C 6 alkylene), or hydroxy(C 1 -C 6 alkylene), wherein x and y are each independently an integer from 1 to 10.
  • R 1 , R 2 , R 3 , and R 4 are each independently hydrogen, hydroxy, or C 1 -C 12 alkyl, and x and y is each independently an integer from 1 to 6. More preferably R 1 , R 2 , R 3 , and R 4 is each independently hydrogen or C 1 -C 6 alkyl.
  • R 5 in structure I is a hydrogen or methyl group, and is preferably a methyl group.
  • M in structure I is a carbonyl-containing group, in particular wherein G and J are each independently oxygen or NR 6 , wherein R 6 is hydrogen or C 1 -C 6 alkyl; and m is 1, 2, 3, or 4.
  • M is wherein G is oxygen, and m is 1, 2, or 3.
  • a is 1, n+m+q is 1, 2, 3, or 4, and when a is 0, n+m+is 1, 2, 3, 4, 5, or 6.
  • W in structure I is a hydrocarbyl linking group having a valency corresponding to z, the number of (meth)acrylate groups, plus one.
  • W may be aromatic or aliphatic. Suitable aromatic groups are phenyl and napthyl, and suitable aliphatic groups are C 1 -C 12 alkyl, cycloalkyl, alkenyl, or alkynyl groups.
  • the improved dental resin composition comprises a polymerizable (meth)acrylate of the general structure III:
  • n, q, M, A, and a are as described above.
  • a is 0 and n is 0 or 1.
  • R 1 , R 2 , R 3 , R 4 , R 5 , x, and y are as described above.
  • R 6 and R 7 are each independently hydrogen, hydroxy, C 1 -C 12 alkyl, C 1 -C 12 perhaloalkyl, C 1 -C 12 alkoxy, C 1 -C 12 perhaloalkoxy, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, (C 1 -C 6 alkyl)-O-(C 1 -C 6 alkylene), or hydroxy(C 1 -C 6 alkylene), wherein z is an integer of 1 to 5, preferably 1 to 3.
  • R 1 , R 2 , R 3 , R 4 , R 6 , and R 7 are each independently hydrogen, hydroxy, or C 1 -C 12 alkyl, and x and y is each independently an integer from 1 to 6. More preferably R 1 , R 2 , R 3 , R 4 , R 6 , and R 7 is each independently hydrogen or C 1 -C 6 alkyl.
  • the polymerizable (meth)acrylate (I) may be synthesized, for example, from the reaction of a hydroxy-containing (meth)acrylate monomer and an aromatic compound comprising anhydride or carboxylic acid functionality or their synthetic equivalents (e.g., a carboxylic acid halide, for example chloride).
  • An exemplary synthetic preparation includes the reaction of one mole of an aromatic anhydride, for example benzenetetracarboxylic acid dianhydride (BTAD) or pyromellitic dianhydride (PMDA), with two moles of a hydroxy-containing (meth)acrylate, for example caprolactone 2-(methacryloyloxy)ethyl ester (CLMA, or 2-(6-hydroxy-1-oxo-hexyloxy)ethyl methacrylate), at elevated temperature in the presence of a catalyst, for example a catalytic amount of stannous ethylhexanoate (SEH).
  • a catalyst for example a catalytic amount of stannous ethylhexanoate (SEH).
  • SEH stannous ethylhexanoate
  • Any number of the remaining carboxylic acid groups may further be reacted with an additional hydroxy-containing (meth)acrylate monomer to form a modified polymerizable (meth)acrylate.
  • the ratio of moles of hydroxy-containing (meth)acrylate monomer to moles of anhydride or carboxylic acid, as well as the reaction conditions and/or starting materials, may be varied to provide a wide range of polymerizable (meth)acrylate products.
  • Exemplary aromatic compounds comprising anhydride functionality, carboxylic acid functionality, or a combination thereof useful to prepare the polymerizable (meth)acrylate of structure I include BTAD, PMDA, all isomers of benzenetetracarboxylic acid, preferably benzene-1,2,4,5-tetracarboxylic acid, 1,3-dihydro-1,3-dioxoisobenzofuran-4,5-dicarboxylic acid, 1,3-dihydro-1,3-dioxoisobenzofuran-5,6-dicarboxylic acid, trimellitic anhydride, trimellitic acid, terephthalic acid, phthalic acid, phthalic anhydride, benzoic acid, 4′-(4,4′-isopropylidenediphenoxy)-bis(phthalic anhydride) (IBA), and the like.
  • BTAD benzene-1,2,4,5-tetracarboxylic acid
  • Preferred aromatic anhydride and/or carboxylic acid compounds include BTAD, 1,3-dihydro-1,3-dioxoisobenzofuran-4,5-dicarboxylic acid, PMDA, benzene-1,2,4,5-tetracarboxylic acid, 1,3-dihydro-1,3-dioxoisobenzofuran-5,6-dicarboxylic acid, trimellitic anhydride, and trimellitic acid.
  • Suitable hydroxy-containing (meth)acrylate monomers include, for example, those of the general structure II: wherein R 1 , R 2 , R 3 , R 4 , x, y, and M are as described above.
  • a preferred hydroxy-containing (meth)acrylate monomer is a compound according to structure II wherein R 1 , R 2 , R 3 , and R 4 are each hydrogen; x and y are each independently an integer from 1 to 5; M is wherein G is oxygen; and R 5 is hydrogen or methyl, more preferably methyl.
  • suitable hydroxy-containing (meth)acrylate monomers according to structure II include CLMA, caprolactone 2-(acryloyloxy) ethyl ester, and 3-hydroxy-1-oxopropyl (meth)acrylate.
  • the most preferred hydroxy-containing (meth)acrylate monomers are CLMA and caprolactone 2-(acryloyloxy)ethyl ester. Mixtures of two or more different hydroxy-containing (meth)acrylates of formula II may also be used.
  • CLMA may be prepared by the condensation of ⁇ -caprolactone and 2-hydroxyethyl methacrylate.
  • isocyanate alkyl (meth)acrylate e.g., isocyanate methyl (meth)acrylate
  • a suitably monoprotected amino alcohol or dialcohol followed by deprotection to result in a hydroxy-containing methacrylate comprising urea or carbamate functionality.
  • the ratio of moles of hydroxy-containing (meth)acrylate monomer to the moles of aromatic anhydride, carboxylic acid, or its equivalent may be selected to obtain a resin that provides desired properties of adhesion and reduced shrinkage upon polymerization.
  • the ratio of moles of hydroxy-containing (meth)acrylate monomer to moles of aromatic anhydride and/or carboxylic acid may be about 0.1 to about 5, preferably about 0.5 to about 4, more preferably about 0.75 to about 3, and yet more preferably about 1 to about 2.
  • the catalyst used to prepare the polymerizable (meth)acrylate according to the general structure (I) may be selected from metal organic catalysts comprising tin or titanium.
  • tin-containing catalysts are dibutyltin dilaurate, dibutyltin maleate, dibutyltin diacetate, dioctyltin maleate, dibutyltin phthalate, stannous octoate, stannous naphthenate, stannous stearate, stannous 2-ethyl hexanoate, dibutyltin diacetylacetonate, dibutyltin oxide, and combinations comprising at least one of the foregoing tin based catalysts.
  • titanium-based catalysts are tetrabutyl titanate, tetrapropyl titanate, tetraisopropyl titanate, triethanolamine titanate, titanium tetraacetylacetonate, and combinations comprising at least one of the foregoing titanium based catalysts.
  • the preferred catalysts are stannous octoate or stannous 2-ethyl hexanoate.
  • the catalyst in an amount of about 0.10 to about 10 mole percent based on the total moles of the reactant mixture. Within this range it is generally desirable to utilize the catalyst in an amount about 1 to about 8, preferably about 2 to about 7, and most preferably about 3 to about 6 mole percent based on the total moles of the reactants.
  • the polymerizable (meth)acrylate of structure (I) may be formed by reaction of an aromatic compound comprising anhydride functionality, carboxylic acid functionality, or a combination thereof with a mixture comprising a hydroxy-containing (meth)acrylate of formula II and an additional, different hydroxy-containing methacrylate of formula IV: wherein W and R 5 are as defined above.
  • Exemplary suitable hydroxy-containing (meth)acrylate monomers of this type include compounds comprising two or more (meth)acrylate groups, for example, glyceryl di(meth)acrylate, glycerol di(meth)acrylate, trimethylolpropane di(meth)acrylate; pentaerythritol tri(meth)acrylate and the like.
  • the different hydroxy-containing (meth)acrylate is of structure V: wherein R 6 and R 7 are each independently hydrogen, hydroxy, C 1 -C 12 alkyl, C 1 -C 12 perhaloalkyl, C 1 -C 12 alkoxy, C 1 -C 12 perhaloalkoxy, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, (C 1 -C 6 alkyl)-O-(C 1 -C 6 alkylene), or hydroxy(C 1 -C 6 alkylene); z is an integer from 1 to 10; and R 5 is hydrogen or methyl.
  • the additional hydroxy (meth)acrylate according to structure V comprises a compound wherein R 6 and R 7 are each independently hydrogen, C 1 -C 12 alkyl, or hydroxy; and z is an integer from 1 to 10; and R 5 is methyl.
  • exemplary compounds include 2-hydroxyethyl methyacrylate (HEMA), 2-hydroxyethyl acrylate, hydroxypropyl (meth)acrylate, and glyceryl mono(meth)acrylate. Mixtures of the additional monomers may also be used.
  • the ratio of the moles of additional hydroxy-containing (meth)acrylate monomer to moles of anhydride and/or carboxylic acid of structure I, monomer II, and the additional monomer(s) may be selected to provide a modified polymerizable (meth)acrylate possessing desired properties.
  • the ratio of moles of additional hydroxy-containing (meth)acrylate monomer to moles of anhydride and/or carboxylic acid groups of structure (I) may be about 0.1:1 to about 5:1, preferably about 0.5:1 to about 4:1, more preferably about 0.75:1 to about 3:1, and yet more preferably about 1:1 to about 2:1.
  • An exemplary polymerizable (meth)acrylate in accordance with the present invention is the reaction product of BTAD with CLMA, having structures VIa and/or VIb as follows:
  • Another exemplary polymerizable (meth)acrylate in accordance with the present invention is the reaction product of BTAD with mixtures of CLMA and HEMA, having the structure (VIIa) and/or (VIIb) as follows:
  • the polymerizable (meth)acrylates may be used alone or in combination with other co-polymerizable, ethylenically unsaturated monomers and/or oligomers.
  • co-polymerizable, ethylenically unsaturated monomers and/oligomers containing carboxylic acid(s), phosphoric acid(s), sulfonic acid(s) or their anhydride(s) may be utilized in combination with the polymerizable (meth)acrylates of this invention.
  • Mixtures comprising the polymerizable (meth)acrylate and other components such as polymerization initiators, additives, and fillers may be prepared to form dental materials suitable for use as dental adhesives, dental cements, dental filling materials, root canal sealing/filling materials, and/or other dental restorative materials such as crown and bridge materials, provisional crown and bridge materials, and the like. It is generally desirable to use the polymerizable (meth)acrylate in an amount of about 1 to about 99 weight percent based on the total weight of the dental restorative material.
  • the polymerizable (meth)acrylate in an amount of about 10 to about 95 weight percent, preferably about 30 to about 90 weight percent, and most preferably about 50 to about 80 weight percent based on the total weight of the dental restorative material.
  • Known viscous resins may be used in combination with the polymerizable (meth)acrylate to provide a dental restorative material.
  • Non-limiting examples include polyurethane dimethacrylates (PUDMA), diurethane dimethacrylates (DUDMA), and/or the polycarbonate dimethacrylate (PCDMA) disclosed in U.S. Pat. Nos. 5,276,068 and 5,444,104 to Waknine, which is the condensation product of two parts of a hydroxyalkylmethacrylate and 1 part of a bis(chloroformate).
  • Another advantageous resin having lower water sorption characteristics is an ethoxylated bisphenol A dimethacrylate (EBPDMA) as disclosed in U.S. Pat. No. 6,013,694 to Jia, et al.
  • Still another useful resin material is disclosed in U.S. Pat. No. 6,787,629 to Jia, et al.
  • An especially useful methacrylate resin is BisGMA.
  • Diluent monomers may be used to increase the surface wettability of the composition and/or to decrease the viscosity of the polymerization medium.
  • Suitable diluent monomers include those known in the art such as hydroxyalkyl (meth)acrylates, for example 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, and 4-hydroxybutyl (meth)acrylate; ethylene glycol (meth)acrylates, including ethylene glycol methacrylate, diethylene glycol methacrylate, tri(ethylene glycol) dimethacrylate and tetra(ethylene glycol) dimethacrylate; and diol dimethacrylates such as 1,4-butanediol di(meth)acrylate, dodecane diol di(meth)acrylate, or 1,6-hexanediol di(meth)acrylate, particularly 1,6-hexanediol dimethacrylate (HDDMA).
  • Suitable monomers include polyethylene glycol mono(meth)acrylate; glycerol di(meth)acrylate; trimethylolpropane di(meth)acrylate; pentaerythritol tri(meth)acrylate; the (meth)acrylate of phenyl glycidyl ether; and the like.
  • Tri(ethylene glycol) dimethacrylate (TEGDMA) is particularly preferred.
  • Diluent monomers or viscous resins when present, are incorporated into the dental restorative materials in an amount of about 1 to about 70 weight percent of the total dental restorative material.
  • the optional filler system may comprise one or more of the inorganic fillers currently used in dental composite materials.
  • Preferred fillers include those, which are capable of being covalently bonded to the polymerizable (meth)acrylate matrix itself or to a coupling agent (e.g., silanes) that is covalently bonded to both.
  • suitable filling materials include but are not limited to, silica, quartz, strontium silicate, strontium borosilicate, lithium silicate, lithium alumina silicate, amorphous silica, ammoniated or deammoniated calcium phosphate, tricalcium phosphate alumina, zirconia, tin oxide, titania and combinations comprising at least one of the foregoing fillers.
  • inorganic filling materials and methods of preparation thereof are known in the art, as disclosed in U.S. Pat. No. 4,544,359 and No. 4,547,531 to Waknine, pertinent portions of which are incorporated herein by reference.
  • Organic-inorganic fillers of POSSTM Hybrid Plastics
  • Other organic-inorganic fillers such as zirconium methacrylate and zirconium dimethacrylate under the codes of CXZR050 and CXZR051 (Gelest, Inc.) can also be used.
  • Suitable high refractive index filler materials such as high refractive index silica glass fillers; calcium silicate based fillers such as apatites, hydroxyapatites or modified hydroxyapatite compositions may also be used.
  • inert, non-toxic radiopaque materials such as bismuth oxide (Bi 2 O 3 ), bismuth oxychloride, zirconium oxide, barium sulfate, and bismuth subcarbonate in micro- or nano scaled sizes may be used.
  • fibrous fillers such as those disclosed in U.S. Pat. Nos. 6,013,694, 6,403,676 and 6,270,562 to Jia and Jia et al. may also be used.
  • Suitable fillers have particle sizes of about 0.01 to about 5.0 micrometers, and may further comprise bound or unbound silicate colloids of about 0.001 to about 0.2 micrometers. These additional fillers may also be treated with a silane-coupling agent to increase adhesion with the polymerizable, (meth)acrylate.
  • silane treated fumed silica based on Aerosil A200 can be obtained from Degussa Corp under the names of Aerosil R711 and R7200.
  • the amount of total filler system in the dental restorative material can vary from about 1 to about 90 weight percent based on the total weight of the dental restorative material.
  • the amount used is determined by the requirements of the particular application.
  • crown and bridge materials generally comprise about 60 to about 90 weight percent filler
  • luting cements comprise about 20 to about 80 weight percent filler
  • sealants generally comprise about 1 to about 20 weight percent filler
  • adhesives generally comprise about 1 to about 30 weight percent filler
  • restorative materials comprise about 50 to about 90 weight percent filler, with the remainder in all cases being the polymerizable (meth)acrylate and other optionally added resins.
  • the polymerizable (meth)acrylate may be used together with a curing system, which generally includes polymerization initiators; polymerization accelerators; ultraviolet light absorbers; antioxidants; and other additives known in the art.
  • a curing system which generally includes polymerization initiators; polymerization accelerators; ultraviolet light absorbers; antioxidants; and other additives known in the art.
  • Suitable polymerization initiators are those initiators that can be utilized in UV-activated cure or visible light-activated cure compositions.
  • visible light-curable compositions employ light-sensitive compounds, including but not being limited to benzil, benzoin, benzoin methyl ether, DL-camphorquinone (CQ), and benzil diketones.
  • Either UV-activated cure or visible light-activated cure (approximately 230 to 750 nanometer) is acceptable.
  • the amount of photoinitiator is selected according to the curing rate desired. A minimal catalytically effective amount is generally about 0.01 weight percent of the total dental resin composition, and will lead to a slower cure.
  • the total dental resin composition is the total weight of the polymerizable (meth)acrylate and other resinous materials, such as for example, resinous diluents, which are used in the dental restorative material.
  • the dental restorative material may be formulated as a self-curing system.
  • Self-curing dental composite materials will generally contain free radical polymerization initiators such as, for example, a peroxide in an amount of about 0.01 to about 1.0 weight percent of the total resin dental composite material.
  • free radical initiators are lauryl peroxide, tributyl hydroperoxide and, more particularly benzoyl peroxide (BPO).
  • Polymerization accelerators suitable for use are the various organic tertiary amines well known in the art.
  • the tertiary amines are generally (meth)acrylate derivatives such as dimethylaminoethyl methacrylate and, particularly, diethylaminoethyl methacrylate (DEAEMA) in an amount of about 0.05 to about 0.5 weight percent of the total dental restorative material.
  • DEAEMA diethylaminoethyl methacrylate
  • the tertiary amines are generally aromatic tertiary amines, preferably tertiary aromatic amines such as ethyl 4-(dimethylamino)benzoate (EDMAB), 2-[4-(dimethylamino)phenyl]ethanol, N,N-dimethyl-p-toluidine (DMPT), and bis(hydroxyethyl)-p-toluidine (DHEPT).
  • EDMAB ethyl 4-(dimethylamino)benzoate
  • DMPT N,N-dimethyl-p-toluidine
  • DHEPT bis(hydroxyethyl)-p-toluidine
  • Such accelerators are generally present in an amount of about 0.5 to about 4.0 weight percent of the total dental restorative material.
  • an ultraviolet absorber in an amount of about 0.05 to about 5.0 weight percent of the total dental restorative material.
  • Such UV absorbers are particularly desirable in the visible light-curable dental restorative materials in order to avoid discoloration of the resin from incident ultraviolet light.
  • Suitable UV absorbers are the various benzophenones, particularly UV-5411 available from American Cyanamid Company.
  • the polymerizable (meth)acrylate is prepared by reacting an aromatic compound comprising anhydride and/or carboxylic acid functionality with a hydroxy-containing (meth)acrylate monomer in the presence of a catalyst.
  • the resulting polymerizable (meth)acrylate is then formulated into a dental restorative material by mixing with the filler system and the curing system.
  • the dental restorative material is then applied to the tooth to be repaired, and cured.
  • the dental restorative material may be formulated as a two-part system, wherein the first part can comprise the polymerizable (meth)acrylate and the filler system.
  • the second part can comprise the curing system and optional diluent monomers.
  • the two parts are metered out and then mixed using a spatula.
  • the cure may be initiated through the use of UV light or by raising the temperature of the mixture.
  • the dental restorative material thus obtained is then placed in the tooth to be restored after the tooth is appropriately prepared.
  • (meth)acrylate is intended to encompass both acrylate and methacrylate groups. All ranges disclosed herein are inclusive and combinable. In addition, all patents are incorporated by reference in their entirety.
  • BTAD 1,2,4,5-benzenetetracarboxylic dianhydride
  • CLMA 2-(caprolactone)ethyl methacrylate
  • HEMA 2-hydroxyethyl methacrylate
  • SEH tin(II) 2-ethylhexanoate
  • the synthesized resins BTAD-CLMA and BTAD-CLMA-HEMA were each mixed with a conventional resin and diluent (PUDMA and HDDMA)in a weight ratio of 50/40/10. Quantities of 0.2 wt % CQ and 0.4 wt % EDMAB were added as photoinitiators. The samples were cured for a total four minutes using visible light with CureLiteTM Plus curing box (Pentron Corp.) Samples were then trimmed and stored in water at 37° C. for 24 hours before testing.
  • Resin 1 and Resin 2 were further used to make a light-curable dental composite with the addition of treated silica filler (R7200 from Degussa), a sol-gel processed zirconium silicate filler as disclosed in U.S. Patent Publ. No. 2003/0125444 A1 and Schott glass filler (Schott 8235, available from Schott Electronic Packaging Gmbh, Germany).
  • treated silica filler R7200 from Degussa
  • a sol-gel processed zirconium silicate filler as disclosed in U.S. Patent Publ. No. 2003/0125444 A1 and Schott glass filler (Schott 8235, available from Schott Electronic Packaging Gmbh, Germany).
  • the same filler combination and loading (78 wt. % filler) were used in to form Composite 1 from Resin 1 and Composite 2 from Resin 2.
  • the composites were tested and the MOR results are shown in Table 2.
  • Samples of self-curing compositions with and without BTAD-CLMA in the catalyst part were prepared to evaluate the effect BTAD-CLMA on cure.
  • the samples, designated SC1 and SC2 were each formed from two paste components, a catalyst paste and a base paste.
  • the catalyst past and base paste were each prepared from a resin and a filler that have the compositions shown in Table 3.
  • the SC1 catalyst resin contains 10 wt. % of BTAD-CLMA, while SC2 does not.
  • Other components for samples SC1 and SC2 are similar.
  • Catalyst paste 1 and Catalyst paste 2 were mixed in 1:1 wt. ratio with the base paste.
  • Base resin catalyst Base resin: DHEPT 1.5 wt %, BHT and base DHEPT 1.5 wt %, BHT 0.05 wt % in EBPADMA pastes 0.05 wt % in EBPADMA Paste
  • Catalyst paste 1 Catalyst paste 2: Compo- Catalyst resin 1: 35 Catalyst resin 2: 35 nents wt % wt %
  • Filler 65 wt % of Filler: 65 wt % of treated silica and treated silica and glass filler glass filler
  • Base paste Base paste: Base resin: 30 wt % Base resin: 30 wt % Filler: 70 wt % of Filler: 70 wt % of treated silica and treated silica and glass filler, barium glass filler, barium sulfate and calcium sulfate and calcium hydroxide hydroxide
  • FIGURE shows the stability test results of samples SC1 and SC2 at room temperature for 8 weeks.
  • Sample SC1 shows stable gel time and setting time during the 8 weeks storage at room temperature, but sample SC2 shows increasing gel time and setting time.
  • the present polymerizable (meth)acrylates resins can be used to prepare a light curable, one-component adhesive composite for tooth restorations, wherein the composites can be used without a separate dental bonding procedure prior to a the application of the material. Such procedures can be time-consuming, and their elimination is highly advantageous.
  • compositions per Components Function in the composition hundred BTAD-CLMA-HEMA Resin matrix component and 20 adhesion promoter HEMA A co-polymerizable resin 20 diluent and hydrophilicity modifier for the composition
  • compositions have a flowable consistency, which allows delivery of the composite through a cannula, for example a needle tip directly onto a tooth surface. Again, it has been found that a separate bonding procedure, i.e. an additional bonding adhesive is not necessary.
  • These compositions may be used, for example, for cementing a veneer, lining a tooth cavity underneath a regular dental restorative composite, sealing a root canal coronal end, placing as a direct tooth filling, securing an orthodontic bracket, or the like.
  • the present polymerizable (meth)acrylates resins can be used to prepare self and/or dual-curable two-component composites suitable for use as an adhesive luting cement, a core build-up material, a root canal filling/sealing material, or the like. In an advantageous feature, use of a separate bonding procedure before using the composite material is not necessary.
  • An exemplary composition is illustrated in the table below.
  • the working time and setting time of the above composition is about three minutes and four and half minutes, respectively, when the base and catalyst is mixed in 1:1 ratio by volume and the material is not subject to a second curing process.
  • dual-cure mode when the material, upon mixing the base and catalyst, is subject to a dental visible light-curing source, the mass of the material will harden immediately upon the photoinitiation.
  • the Table below shows the results of cementation/bonding tests of the present polymerizable (meth)acrylates resin composite compositions between dentin and a ceramic (3GTM ceramic material, Pentron Corp., Wallingford, Conn.).
  • the bonding test method was as follows:
  • 3GTM ceramic rods were fabricated with a dental porcelain furnace according to the ceramic firing temperature and conditions of the product.
  • the 3GTM ceramic rods used for the bonding test have final dimensions of about 3.2 mm diameter and 6-8 mm length, on which one end of the rod was sandblasted, cleaned and then silane treated as per the product instructions. The treated end will be contacting the bonding cement as in a tooth restoration.
  • Each test group contains 5 samples.
  • Teeth samples were prepared to expose the dentin and then the teeth were mounted with an acrylic material leaving the dentin exposed, which were then subject to sand paper grinding under wet condition to have a same surface pattern for all the test groups.
  • the cement materials were mixed according to the product instructions and applied onto the prepared, briefly dried tooth surface.
  • the ceramic rod was then seated onto the cement surface under a 500 gram load with the aid of a BenCor Multi-test device (Danville Engineering, CA).
  • TM resin 0.3 (1.2) A paste-paste conven- cement, shade A2 tional methacrylate resin cement as a control and used without a separated bonding procedure before the applica- tion of the cement available from Pen- tron Corp., Walling- ford, CT. Lute-It TM resin 14.8 (1.6) Before apply the cement, shade A2, mixed cement onto used in conjunc- the tooth surface, a tion with Bond-1 TM separated bonding dental adhesive procedure is per- formed per the in- struction of the Bond-1 TM dental bonding system, available from Pentron Corp., Wallingford, CT.

Abstract

A composition is disclosed comprising a polymerizable (meth)acrylate of the structure:
Figure US20050192374A1-20050901-C00001

wherein A is an anhydride; a is 0 or 1; n is 0, 1, 2, or 3; R1, R2, R3, and R4 are each independently hydrogen, hydroxy, C1-C12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene); x and y are each independently an integer of 1 to 10; z is an integer of 1 to 5; R5 is hydrogen or methyl; M is
Figure US20050192374A1-20050901-C00002

wherein G and J are each independently O or NR6, wherein R6 is hydrogen or C1-C6 alkyl; m is 1, 2, 3, or 4; W is an organic group having the valency of z+1; and q is 0 or 1; and further wherein when a is 1, n+m+q is 1, 2, 3, or 4, and when a is 0, n+m+q is 1, 2, 3, 4, 5, or 6. The composition finds use as a dental resin.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Patent Application Ser. No. 60/540,148 filed Jan. 29, 2004.
  • BACKGROUND
  • This invention relates to dental resin compositions comprising polymerizable (meth)acrylate resins, their method of manufacture, and the use of such resins for restorative dentistry, including dental adhesives, dental cements, dental filling materials, root canal sealants, crown and bridge materials, and the like.
  • In recent years, materials used for dental restorations have principally comprised acrylate or methacrylate resins. Resinous materials of this type are disclosed, for example, in U.S. Pat. No. 3,066,112 to Bowen, No. 3,194,784 to Bowen, and No. 3,926,906 to Lee et al. An especially important methacrylate monomer is the condensation product of bisphenol A and glycidyl methacrylate, 2,2′-bis[4-(3-methacryloxy-2-hydroxy propoxy)-phenyl]-propane (“BisGMA”). Alternatively, BisGMA may be synthesized from the diglycidyl ether of bisphenol A and methacrylic acid (see, e.g., U.S. Pat. No. 3,066,112 to Bowen).
  • Because the wear and abrasion characteristics and the overall physical, mechanical, and optical properties of these unfilled acrylic resinous materials is poor, and because acrylic resin systems exhibit high coefficients of thermal expansion relative to the coefficient of thermal expansion of the tooth structure, these substances by themselves are less than satisfactory. In particular, the disparity in thermal expansion coupled with high shrinkage upon polymerization results in poor marginal adaptability, and ultimately leads to secondary decay. Composite dental restorative materials containing acrylate or methacrylate resins and fillers were thus developed. The fillers are generally inorganic materials based on silica, silicate based glasses, or quartz. These filled compositions are useful for a variety of dental treatments and restorative functions including crown and bridge materials, fillings, adhesives, sealants, luting agents or cements, denture base materials, orthodontic materials and sealants, and other dental restorative materials. Despite their suitability for their intended purposes, however, many of these materials have shrinkages of about two to about four percent by volume upon polymerization.
  • There accordingly remains a need in the art for dental resin materials that have good bonding adhesion to a dental substrate and minimal shrinkage upon polymerization without sacrificing other advantageous physical properties.
  • SUMMARY
  • The above-described need is met by a composition comprising a polymerizable (meth)acrylate of general structure I:
    Figure US20050192374A1-20050901-C00003

    wherein
      • A is an anhydride;
      • a is 0 or 1;
      • n is 0, 1, 2, or 3;
      • R1, R2, R3, and R4 are each independently hydrogen, hydroxy, C1-C12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene);
      • x and y are each independently an integer of 1 to 10;
      • z is an integer of 1 to 5;
      • R5 is hydrogen or methyl;
        Figure US20050192374A1-20050901-C00004
      • wherein G and J are each independently O or NR6, wherein R6 is hydrogen or C1-C6 alkyl;
      • m is 1, 2, 3, or 4;
      • W is an organic group having the valency of z+1; and
      • q is 0 or 1,
        and further wherein when a is 1, n+m+q is 1, 2, 3, or 4, and when a is 0, n+m+q is 1, 2, 3, 4, 5, or 6.
  • In another embodiment, a method of manufacturing a composition comprising a polymerizable (meth)acrylate comprises reacting a hydroxy-containing (meth)acrylate monomer of structure II:
    Figure US20050192374A1-20050901-C00005

    wherein
      • R1, R2, R3, and R4 are each independently hydrogen, hydroxy, C1-C12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene);
      • x and y are each independently an integer from 1 to 10;
      • R5 is hydrogen or methyl; and
        Figure US20050192374A1-20050901-C00006
      • wherein G and J are each independently O or NR6, wherein R6 is hydrogen or C1-C6 alkyl,
        with an aromatic compound comprising anhydride functionality, carboxylic acid functionality, or a combination thereof
  • In yet another embodiment, a method of making a dental restoration comprises applying to a site to be restored a composition comprising the above-described polymerizable (meth)acrylate of general structure I, and polymerizing the (meth)acrylate.
  • BRIEF DESCRIPTION OF THE FIGURE
  • The FIGURE is a graph illustrating cure time after ageing of a composition in accordance with the present invention and a control.
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • The polymerizable (meth)acrylates described herein are useful as dental resins and possess improved properties over existing dental resins, and correspondingly enhance the properties of dental restorative materials prepared from such resins. For instance, the polymerizable (meth)acrylates provide excellent bonding strength between a dental substrate (dentin, enamel, or other tooth structure) and the dental restorative material made from the polymerizable (meth)acrylate. Additionally, dental restorative materials prepared from the polymerizable (meth)acrylates exhibit reduced shrinkage upon polymerization to provide a better seal between the dental restoration and the repaired tooth.
  • In particular, an improved dental resin is of formula I:
    Figure US20050192374A1-20050901-C00007
  • In structure I, n is 0, 1, 2, or 3, q is 0 or 1, A is an anhydride group, and a is 0 or 1. As is known, the anhydride group (—C(O)—O—C(O)—) is linked via its two carbon atoms to two ortho carbons of the phenyl ring. Preferably, a is 0. In another embodiment, a is 0 and n is preferably 1 or 2.
  • Further in structure I, R1, R2, R3, and R4 are each independently hydrogen, hydroxy, C1-C12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene), wherein x and y are each independently an integer from 1 to 10. In one embodiment, R1, R2, R3, and R4 are each independently hydrogen, hydroxy, or C1-C12 alkyl, and x and y is each independently an integer from 1 to 6. More preferably R1, R2, R3, and R4 is each independently hydrogen or C1-C6 alkyl.
  • R5 in structure I is a hydrogen or methyl group, and is preferably a methyl group.
  • M in structure I is a carbonyl-containing group, in particular
    Figure US20050192374A1-20050901-C00008

    wherein G and J are each independently oxygen or NR6, wherein R6 is hydrogen or C1-C6 alkyl; and m is 1, 2, 3, or 4. Preferably, M is
    Figure US20050192374A1-20050901-C00009

    wherein G is oxygen, and m is 1, 2, or 3. When a is 1, n+m+q is 1, 2, 3, or 4, and when a is 0, n+m+is 1, 2, 3, 4, 5, or 6.
  • W in structure I is a hydrocarbyl linking group having a valency corresponding to z, the number of (meth)acrylate groups, plus one. W may be aromatic or aliphatic. Suitable aromatic groups are phenyl and napthyl, and suitable aliphatic groups are C1-C12 alkyl, cycloalkyl, alkenyl, or alkynyl groups.
  • Thus, in one embodiment, the improved dental resin composition comprises a polymerizable (meth)acrylate of the general structure III:
    Figure US20050192374A1-20050901-C00010
  • In structure III, n, q, M, A, and a are as described above. Preferably, a is 0 and n is 0 or 1.
  • Further in structure I, R1, R2, R3, R4, R5, x, and y are as described above. R6 and R7 are each independently hydrogen, hydroxy, C1-C12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene), wherein z is an integer of 1 to 5, preferably 1 to 3. In one embodiment, R1, R2, R3, R4, R6, and R7 are each independently hydrogen, hydroxy, or C1-C12 alkyl, and x and y is each independently an integer from 1 to 6. More preferably R1, R2, R3, R4, R6, and R7 is each independently hydrogen or C1-C6 alkyl.
  • The polymerizable (meth)acrylate (I) may be synthesized, for example, from the reaction of a hydroxy-containing (meth)acrylate monomer and an aromatic compound comprising anhydride or carboxylic acid functionality or their synthetic equivalents (e.g., a carboxylic acid halide, for example chloride). An exemplary synthetic preparation includes the reaction of one mole of an aromatic anhydride, for example benzenetetracarboxylic acid dianhydride (BTAD) or pyromellitic dianhydride (PMDA), with two moles of a hydroxy-containing (meth)acrylate, for example caprolactone 2-(methacryloyloxy)ethyl ester (CLMA, or 2-(6-hydroxy-1-oxo-hexyloxy)ethyl methacrylate), at elevated temperature in the presence of a catalyst, for example a catalytic amount of stannous ethylhexanoate (SEH). The resulting reaction product contains two (meth)acrylate groups and two carboxylic acid groups. Any number of the remaining carboxylic acid groups may further be reacted with an additional hydroxy-containing (meth)acrylate monomer to form a modified polymerizable (meth)acrylate. The ratio of moles of hydroxy-containing (meth)acrylate monomer to moles of anhydride or carboxylic acid, as well as the reaction conditions and/or starting materials, may be varied to provide a wide range of polymerizable (meth)acrylate products.
  • Exemplary aromatic compounds comprising anhydride functionality, carboxylic acid functionality, or a combination thereof useful to prepare the polymerizable (meth)acrylate of structure I include BTAD, PMDA, all isomers of benzenetetracarboxylic acid, preferably benzene-1,2,4,5-tetracarboxylic acid, 1,3-dihydro-1,3-dioxoisobenzofuran-4,5-dicarboxylic acid, 1,3-dihydro-1,3-dioxoisobenzofuran-5,6-dicarboxylic acid, trimellitic anhydride, trimellitic acid, terephthalic acid, phthalic acid, phthalic anhydride, benzoic acid, 4′-(4,4′-isopropylidenediphenoxy)-bis(phthalic anhydride) (IBA), and the like. Preferred aromatic anhydride and/or carboxylic acid compounds include BTAD, 1,3-dihydro-1,3-dioxoisobenzofuran-4,5-dicarboxylic acid, PMDA, benzene-1,2,4,5-tetracarboxylic acid, 1,3-dihydro-1,3-dioxoisobenzofuran-5,6-dicarboxylic acid, trimellitic anhydride, and trimellitic acid.
  • Suitable hydroxy-containing (meth)acrylate monomers include, for example, those of the general structure II:
    Figure US20050192374A1-20050901-C00011

    wherein R1, R2, R3, R4, x, y, and M are as described above.
  • A preferred hydroxy-containing (meth)acrylate monomer is a compound according to structure II wherein R1, R2, R3, and R4 are each hydrogen; x and y are each independently an integer from 1 to 5; M is
    Figure US20050192374A1-20050901-C00012

    wherein G is oxygen; and R5 is hydrogen or methyl, more preferably methyl. Non-limiting examples of suitable hydroxy-containing (meth)acrylate monomers according to structure II include CLMA, caprolactone 2-(acryloyloxy) ethyl ester, and 3-hydroxy-1-oxopropyl (meth)acrylate. The most preferred hydroxy-containing (meth)acrylate monomers are CLMA and caprolactone 2-(acryloyloxy)ethyl ester. Mixtures of two or more different hydroxy-containing (meth)acrylates of formula II may also be used.
  • Methods of synthesizing the hydroxy-containing (meth)acrylate monomers according to structure II can be found in the art. For example, CLMA may be prepared by the condensation of ε-caprolactone and 2-hydroxyethyl methacrylate. In yet another exemplary synthetic scheme, isocyanate alkyl (meth)acrylate (e.g., isocyanate methyl (meth)acrylate) may be reacted with a suitably monoprotected amino alcohol or dialcohol followed by deprotection to result in a hydroxy-containing methacrylate comprising urea or carbamate functionality.
  • When the polymerizable (meth)acrylate is prepared by the reaction of a hydroxy-containing (meth)acrylate monomer with an aromatic anhydride and/or carboxylic acid, the ratio of moles of hydroxy-containing (meth)acrylate monomer to the moles of aromatic anhydride, carboxylic acid, or its equivalent may be selected to obtain a resin that provides desired properties of adhesion and reduced shrinkage upon polymerization. The ratio of moles of hydroxy-containing (meth)acrylate monomer to moles of aromatic anhydride and/or carboxylic acid may be about 0.1 to about 5, preferably about 0.5 to about 4, more preferably about 0.75 to about 3, and yet more preferably about 1 to about 2.
  • The catalyst used to prepare the polymerizable (meth)acrylate according to the general structure (I) may be selected from metal organic catalysts comprising tin or titanium. Suitable non-limiting examples of tin-containing catalysts are dibutyltin dilaurate, dibutyltin maleate, dibutyltin diacetate, dioctyltin maleate, dibutyltin phthalate, stannous octoate, stannous naphthenate, stannous stearate, stannous 2-ethyl hexanoate, dibutyltin diacetylacetonate, dibutyltin oxide, and combinations comprising at least one of the foregoing tin based catalysts. Suitable non-limiting examples of titanium-based catalysts are tetrabutyl titanate, tetrapropyl titanate, tetraisopropyl titanate, triethanolamine titanate, titanium tetraacetylacetonate, and combinations comprising at least one of the foregoing titanium based catalysts. The preferred catalysts are stannous octoate or stannous 2-ethyl hexanoate.
  • It is generally desirable to use the catalyst in an amount of about 0.10 to about 10 mole percent based on the total moles of the reactant mixture. Within this range it is generally desirable to utilize the catalyst in an amount about 1 to about 8, preferably about 2 to about 7, and most preferably about 3 to about 6 mole percent based on the total moles of the reactants.
  • In another embodiment, the polymerizable (meth)acrylate of structure (I) may be formed by reaction of an aromatic compound comprising anhydride functionality, carboxylic acid functionality, or a combination thereof with a mixture comprising a hydroxy-containing (meth)acrylate of formula II and an additional, different hydroxy-containing methacrylate of formula IV:
    Figure US20050192374A1-20050901-C00013

    wherein W and R5 are as defined above. Exemplary suitable hydroxy-containing (meth)acrylate monomers of this type include compounds comprising two or more (meth)acrylate groups, for example, glyceryl di(meth)acrylate, glycerol di(meth)acrylate, trimethylolpropane di(meth)acrylate; pentaerythritol tri(meth)acrylate and the like. Preferably, the different hydroxy-containing (meth)acrylate is of structure V:
    Figure US20050192374A1-20050901-C00014

    wherein R6 and R7 are each independently hydrogen, hydroxy, C1-C12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene); z is an integer from 1 to 10; and R5 is hydrogen or methyl. In a preferred embodiment, the additional hydroxy (meth)acrylate according to structure V comprises a compound wherein R6 and R7 are each independently hydrogen, C1-C12 alkyl, or hydroxy; and z is an integer from 1 to 10; and R5 is methyl. Exemplary compounds include 2-hydroxyethyl methyacrylate (HEMA), 2-hydroxyethyl acrylate, hydroxypropyl (meth)acrylate, and glyceryl mono(meth)acrylate. Mixtures of the additional monomers may also be used.
  • When the polymerizable (meth)acrylate of structure I comprising free anhydride and/or carboxylic acid groups is reacted with an additional hydroxy-containing (meth)acrylate monomer, the ratio of the moles of additional hydroxy-containing (meth)acrylate monomer to moles of anhydride and/or carboxylic acid of structure I, monomer II, and the additional monomer(s) may be selected to provide a modified polymerizable (meth)acrylate possessing desired properties. Generally the ratio of moles of additional hydroxy-containing (meth)acrylate monomer to moles of anhydride and/or carboxylic acid groups of structure (I) may be about 0.1:1 to about 5:1, preferably about 0.5:1 to about 4:1, more preferably about 0.75:1 to about 3:1, and yet more preferably about 1:1 to about 2:1.
  • An exemplary polymerizable (meth)acrylate in accordance with the present invention is the reaction product of BTAD with CLMA, having structures VIa and/or VIb as follows:
    Figure US20050192374A1-20050901-C00015

    Another exemplary polymerizable (meth)acrylate in accordance with the present invention is the reaction product of BTAD with mixtures of CLMA and HEMA, having the structure (VIIa) and/or (VIIb) as follows:
    Figure US20050192374A1-20050901-C00016
  • The polymerizable (meth)acrylates may be used alone or in combination with other co-polymerizable, ethylenically unsaturated monomers and/or oligomers. For example, one or more other co-polymerizable, ethylenically unsaturated monomers and/oligomers containing carboxylic acid(s), phosphoric acid(s), sulfonic acid(s) or their anhydride(s) may be utilized in combination with the polymerizable (meth)acrylates of this invention. Mixtures comprising the polymerizable (meth)acrylate and other components such as polymerization initiators, additives, and fillers may be prepared to form dental materials suitable for use as dental adhesives, dental cements, dental filling materials, root canal sealing/filling materials, and/or other dental restorative materials such as crown and bridge materials, provisional crown and bridge materials, and the like. It is generally desirable to use the polymerizable (meth)acrylate in an amount of about 1 to about 99 weight percent based on the total weight of the dental restorative material. Within this range it is generally desirable to use the polymerizable (meth)acrylate in an amount of about 10 to about 95 weight percent, preferably about 30 to about 90 weight percent, and most preferably about 50 to about 80 weight percent based on the total weight of the dental restorative material.
  • Known viscous resins may be used in combination with the polymerizable (meth)acrylate to provide a dental restorative material. Non-limiting examples include polyurethane dimethacrylates (PUDMA), diurethane dimethacrylates (DUDMA), and/or the polycarbonate dimethacrylate (PCDMA) disclosed in U.S. Pat. Nos. 5,276,068 and 5,444,104 to Waknine, which is the condensation product of two parts of a hydroxyalkylmethacrylate and 1 part of a bis(chloroformate). Another advantageous resin having lower water sorption characteristics is an ethoxylated bisphenol A dimethacrylate (EBPDMA) as disclosed in U.S. Pat. No. 6,013,694 to Jia, et al. Still another useful resin material is disclosed in U.S. Pat. No. 6,787,629 to Jia, et al. An especially useful methacrylate resin is BisGMA.
  • Diluent monomers may be used to increase the surface wettability of the composition and/or to decrease the viscosity of the polymerization medium. Suitable diluent monomers include those known in the art such as hydroxyalkyl (meth)acrylates, for example 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, and 4-hydroxybutyl (meth)acrylate; ethylene glycol (meth)acrylates, including ethylene glycol methacrylate, diethylene glycol methacrylate, tri(ethylene glycol) dimethacrylate and tetra(ethylene glycol) dimethacrylate; and diol dimethacrylates such as 1,4-butanediol di(meth)acrylate, dodecane diol di(meth)acrylate, or 1,6-hexanediol di(meth)acrylate, particularly 1,6-hexanediol dimethacrylate (HDDMA). Other suitable monomers include polyethylene glycol mono(meth)acrylate; glycerol di(meth)acrylate; trimethylolpropane di(meth)acrylate; pentaerythritol tri(meth)acrylate; the (meth)acrylate of phenyl glycidyl ether; and the like. Tri(ethylene glycol) dimethacrylate (TEGDMA) is particularly preferred.
  • Diluent monomers or viscous resins, when present, are incorporated into the dental restorative materials in an amount of about 1 to about 70 weight percent of the total dental restorative material.
  • The optional filler system may comprise one or more of the inorganic fillers currently used in dental composite materials. Preferred fillers include those, which are capable of being covalently bonded to the polymerizable (meth)acrylate matrix itself or to a coupling agent (e.g., silanes) that is covalently bonded to both. Examples of suitable filling materials include but are not limited to, silica, quartz, strontium silicate, strontium borosilicate, lithium silicate, lithium alumina silicate, amorphous silica, ammoniated or deammoniated calcium phosphate, tricalcium phosphate alumina, zirconia, tin oxide, titania and combinations comprising at least one of the foregoing fillers. Some of the aforementioned inorganic filling materials and methods of preparation thereof are known in the art, as disclosed in U.S. Pat. No. 4,544,359 and No. 4,547,531 to Waknine, pertinent portions of which are incorporated herein by reference. Organic-inorganic fillers of POSS™ (Hybrid Plastics) can be incorporated into the composites as disclosed in U.S. Patent Application Publication 2002/0198282 A1. Other organic-inorganic fillers such as zirconium methacrylate and zirconium dimethacrylate under the codes of CXZR050 and CXZR051 (Gelest, Inc.) can also be used. Suitable high refractive index filler materials such as high refractive index silica glass fillers; calcium silicate based fillers such as apatites, hydroxyapatites or modified hydroxyapatite compositions may also be used. Alternatively, inert, non-toxic radiopaque materials such as bismuth oxide (Bi2O3), bismuth oxychloride, zirconium oxide, barium sulfate, and bismuth subcarbonate in micro- or nano scaled sizes may be used. In addition, fibrous fillers such as those disclosed in U.S. Pat. Nos. 6,013,694, 6,403,676 and 6,270,562 to Jia and Jia et al. may also be used.
  • Suitable fillers have particle sizes of about 0.01 to about 5.0 micrometers, and may further comprise bound or unbound silicate colloids of about 0.001 to about 0.2 micrometers. These additional fillers may also be treated with a silane-coupling agent to increase adhesion with the polymerizable, (meth)acrylate. Commercially available silane treated fumed silica based on Aerosil A200 can be obtained from Degussa Corp under the names of Aerosil R711 and R7200.
  • The amount of total filler system in the dental restorative material can vary from about 1 to about 90 weight percent based on the total weight of the dental restorative material. The amount used is determined by the requirements of the particular application. Thus, for example, crown and bridge materials generally comprise about 60 to about 90 weight percent filler; luting cements comprise about 20 to about 80 weight percent filler; sealants generally comprise about 1 to about 20 weight percent filler; adhesives generally comprise about 1 to about 30 weight percent filler; and restorative materials comprise about 50 to about 90 weight percent filler, with the remainder in all cases being the polymerizable (meth)acrylate and other optionally added resins.
  • The polymerizable (meth)acrylate may be used together with a curing system, which generally includes polymerization initiators; polymerization accelerators; ultraviolet light absorbers; antioxidants; and other additives known in the art.
  • Suitable polymerization initiators are those initiators that can be utilized in UV-activated cure or visible light-activated cure compositions. For example, visible light-curable compositions employ light-sensitive compounds, including but not being limited to benzil, benzoin, benzoin methyl ether, DL-camphorquinone (CQ), and benzil diketones. Either UV-activated cure or visible light-activated cure (approximately 230 to 750 nanometer) is acceptable. The amount of photoinitiator is selected according to the curing rate desired. A minimal catalytically effective amount is generally about 0.01 weight percent of the total dental resin composition, and will lead to a slower cure. Faster rates of cure are achieved with amounts of catalyst in the range from greater than about 0.01 percent to about 5 weight percent of the total dental resin composition. The total dental resin composition is the total weight of the polymerizable (meth)acrylate and other resinous materials, such as for example, resinous diluents, which are used in the dental restorative material.
  • Alternatively, the dental restorative material may be formulated as a self-curing system. Self-curing dental composite materials will generally contain free radical polymerization initiators such as, for example, a peroxide in an amount of about 0.01 to about 1.0 weight percent of the total resin dental composite material. Particularly suitable free radical initiators are lauryl peroxide, tributyl hydroperoxide and, more particularly benzoyl peroxide (BPO).
  • Polymerization accelerators suitable for use are the various organic tertiary amines well known in the art. In visible light-curable dental restorative materials, the tertiary amines are generally (meth)acrylate derivatives such as dimethylaminoethyl methacrylate and, particularly, diethylaminoethyl methacrylate (DEAEMA) in an amount of about 0.05 to about 0.5 weight percent of the total dental restorative material. In the self-curing dental composite materials, the tertiary amines are generally aromatic tertiary amines, preferably tertiary aromatic amines such as ethyl 4-(dimethylamino)benzoate (EDMAB), 2-[4-(dimethylamino)phenyl]ethanol, N,N-dimethyl-p-toluidine (DMPT), and bis(hydroxyethyl)-p-toluidine (DHEPT). Such accelerators are generally present in an amount of about 0.5 to about 4.0 weight percent of the total dental restorative material.
  • It is furthermore preferred to employ an ultraviolet absorber in an amount of about 0.05 to about 5.0 weight percent of the total dental restorative material. Such UV absorbers are particularly desirable in the visible light-curable dental restorative materials in order to avoid discoloration of the resin from incident ultraviolet light. Suitable UV absorbers are the various benzophenones, particularly UV-5411 available from American Cyanamid Company.
  • In one embodiment, the polymerizable (meth)acrylate is prepared by reacting an aromatic compound comprising anhydride and/or carboxylic acid functionality with a hydroxy-containing (meth)acrylate monomer in the presence of a catalyst. The resulting polymerizable (meth)acrylate is then formulated into a dental restorative material by mixing with the filler system and the curing system. The dental restorative material is then applied to the tooth to be repaired, and cured.
  • Alternatively, the dental restorative material may be formulated as a two-part system, wherein the first part can comprise the polymerizable (meth)acrylate and the filler system. The second part can comprise the curing system and optional diluent monomers. When necessary, the two parts are metered out and then mixed using a spatula. The cure may be initiated through the use of UV light or by raising the temperature of the mixture. The dental restorative material thus obtained is then placed in the tooth to be restored after the tooth is appropriately prepared. Methods for use of the above-described compositions are well known in the art.
  • As used herein, the term “(meth)acrylate” is intended to encompass both acrylate and methacrylate groups. All ranges disclosed herein are inclusive and combinable. In addition, all patents are incorporated by reference in their entirety.
  • The invention is further illustrated by the following non-limiting examples.
  • EXAMPLE 1 Synthesis of BTAD-CLMA (Structure VI)
  • In a reaction flask, 1 mole (218 g) of 1,2,4,5-benzenetetracarboxylic dianhydride (BTAD) and 2.05 mole (500 g) of 2-(caprolactone)ethyl methacrylate (CLMA) were mixed and heated in an oil bath while mixing until the mixture becomes liquid. A catalytic amount of tin(II) 2-ethylhexanoate (SEH) was added into the flask slowly and the reaction monitored by Fourier transform infrared spectroscopy (FTIR). The reaction was stopped when the anhydride peak at 1782 cm−1 disappeared. The final product BTAD-CLMA is a viscous liquid.
  • EXAMPLE 2 Synthesis of BTAD-CLMA-HEMA (Structure VII)
  • In a reaction flask, 1 mole (218 g) of 1,2,4,5-benzenetetracarboxylic dianhydride (BTAD), 1.05 mol (500 g) of 2-(caprolactone)ethyl methacrylate (CLMA) and 1 mol (130 g) 2-hydroxyethyl methacrylate (HEMA) was mixed. The mixture was heated in an oil bath while mixing until the mixture became liquid. A catalytic amount of tin(II) 2-ethylhexanoate (SEH) was added into the flask slowly and the reaction monitored by FTIR and stopped when the anhydride peak at 1782 cm−1 disappeared. The final product BTAD-CLMA-HEMA is a viscous liquid.
  • EXAMPLE 3 Light-Curable Compositions Using the Synthesized Resins
  • The synthesized resins BTAD-CLMA and BTAD-CLMA-HEMA were each mixed with a conventional resin and diluent (PUDMA and HDDMA)in a weight ratio of 50/40/10. Quantities of 0.2 wt % CQ and 0.4 wt % EDMAB were added as photoinitiators. The samples were cured for a total four minutes using visible light with CureLite™ Plus curing box (Pentron Corp.) Samples were then trimmed and stored in water at 37° C. for 24 hours before testing.
  • Three point bending strength or flexural strength (MOR) was measured on all samples using an ATS machine as described in ISO 4049 for Resin Based Filling Materials (1997). Results are shown in Table 1, wherein standard deviations are in parentheses.
    TABLE 1
    BTAD-CLMA/ BTAD-CLMA-HEMA/
    UDMA/HDDMA UDMA/HDDMA
    (Resin 1) (Resin 2)
    MOR 97(8) 83(10)
    Mpa (σ)
  • Resin 1 and Resin 2 were further used to make a light-curable dental composite with the addition of treated silica filler (R7200 from Degussa), a sol-gel processed zirconium silicate filler as disclosed in U.S. Patent Publ. No. 2003/0125444 A1 and Schott glass filler (Schott 8235, available from Schott Electronic Packaging Gmbh, Germany). The same filler combination and loading (78 wt. % filler) were used in to form Composite 1 from Resin 1 and Composite 2 from Resin 2. The composites were tested and the MOR results are shown in Table 2.
    TABLE 2
    Composite 1 Composite 2
    MOR 149(12) 124(17)
    Mpa (σ)
  • EXAMPLE 4 Self-Curing Compositions Using the Synthesized Resins
  • Samples of self-curing compositions with and without BTAD-CLMA in the catalyst part were prepared to evaluate the effect BTAD-CLMA on cure. The samples, designated SC1 and SC2, were each formed from two paste components, a catalyst paste and a base paste. The catalyst past and base paste were each prepared from a resin and a filler that have the compositions shown in Table 3. The SC1 catalyst resin contains 10 wt. % of BTAD-CLMA, while SC2 does not. Other components for samples SC1 and SC2 are similar. In each sample, Catalyst paste 1 and Catalyst paste 2, respectively, were mixed in 1:1 wt. ratio with the base paste.
    TABLE 3
    SC1 SC2 (Control)
    Resin Catalyst resin 1: Catalyst resin 2:
    compo- BPO 3 wt %, BHT 0.1 BPO 3 wt %, BHT 0.1
    sitions wt % in BisGMA/HDDMA/ wt % in BisGMA/HDDMA
    used to BTADCLMA (wt. Ratio: (wt. Ratio: 70/30)
    form 60/30/10) Base resin:
    catalyst Base resin: DHEPT 1.5 wt %, BHT
    and base DHEPT 1.5 wt %, BHT 0.05 wt % in EBPADMA
    pastes 0.05 wt % in EBPADMA
    Paste Catalyst paste 1: Catalyst paste 2:
    Compo- Catalyst resin 1: 35 Catalyst resin 2: 35
    nents wt % wt %
    Filler: 65 wt % of Filler: 65 wt % of
    treated silica and treated silica and
    glass filler glass filler
    Base paste: Base paste:
    Base resin: 30 wt % Base resin: 30 wt %
    Filler: 70 wt % of Filler: 70 wt % of
    treated silica and treated silica and
    glass filler, barium glass filler, barium
    sulfate and calcium sulfate and calcium
    hydroxide hydroxide
  • Both samples were allowed to age, and portions of the samples were taken periodically to determine the gel times and setting times. The FIGURE shows the stability test results of samples SC1 and SC2 at room temperature for 8 weeks. Sample SC1 shows stable gel time and setting time during the 8 weeks storage at room temperature, but sample SC2 shows increasing gel time and setting time.
  • EXAMPLE 5
  • The present polymerizable (meth)acrylates resins can be used to prepare a light curable, one-component adhesive composite for tooth restorations, wherein the composites can be used without a separate dental bonding procedure prior to a the application of the material. Such procedures can be time-consuming, and their elimination is highly advantageous. An exemplary composition is illustrated in the table below:
    Parts per
    Components Function in the composition hundred
    BTAD-CLMA-HEMA Resin matrix component and 20
    adhesion promoter
    HEMA A co-polymerizable resin 20
    diluent and hydrophilicity
    modifier for the composition
    Camphorquinone Photo-initiator 0.1
    Lucirin-TPO Co-photo-initiator 0.2
    BHT stabilizer 0.01
    Silane treated barium glass filler 55
    (Schott 8235)
    Amorphous silica Filler and rheology/viscosity 4.69
    (Degussa R 7200) modifier
  • The above composition has a flowable consistency, which allows delivery of the composite through a cannula, for example a needle tip directly onto a tooth surface. Again, it has been found that a separate bonding procedure, i.e. an additional bonding adhesive is not necessary. These compositions may be used, for example, for cementing a veneer, lining a tooth cavity underneath a regular dental restorative composite, sealing a root canal coronal end, placing as a direct tooth filling, securing an orthodontic bracket, or the like.
  • EXAMPLE 6
  • The present polymerizable (meth)acrylates resins can be used to prepare self and/or dual-curable two-component composites suitable for use as an adhesive luting cement, a core build-up material, a root canal filling/sealing material, or the like. In an advantageous feature, use of a separate bonding procedure before using the composite material is not necessary. An exemplary composition is illustrated in the table below.
    Base Catalyst
    Components Paste Paste
    BTAD-CLMA 15
    4-methacryloxyethyl trimellitic anhydride 15
    HEMA 5 20
    UDMA 35
    BisGMA 10
    BHT 0.01 0.1
    EDMAB 0.5
    Camphorquinone 0.2
    DHEPT 1.0
    BPO 2.0
    Silane treated barium glass filler (Schott 8235) 30 5
    Al—Ca—F-silicate filler 15
    BiOCl 35
    Amorphous silica (OX-50) 3.29 7.9
  • In self-cure mode, the working time and setting time of the above composition is about three minutes and four and half minutes, respectively, when the base and catalyst is mixed in 1:1 ratio by volume and the material is not subject to a second curing process. In dual-cure mode, when the material, upon mixing the base and catalyst, is subject to a dental visible light-curing source, the mass of the material will harden immediately upon the photoinitiation.
  • The Table below shows the results of cementation/bonding tests of the present polymerizable (meth)acrylates resin composite compositions between dentin and a ceramic (3G™ ceramic material, Pentron Corp., Wallingford, Conn.). The bonding test method was as follows:
  • 1. 3G™ ceramic rods were fabricated with a dental porcelain furnace according to the ceramic firing temperature and conditions of the product. The 3G™ ceramic rods used for the bonding test have final dimensions of about 3.2 mm diameter and 6-8 mm length, on which one end of the rod was sandblasted, cleaned and then silane treated as per the product instructions. The treated end will be contacting the bonding cement as in a tooth restoration. Each test group contains 5 samples.
  • 2. Teeth samples were prepared to expose the dentin and then the teeth were mounted with an acrylic material leaving the dentin exposed, which were then subject to sand paper grinding under wet condition to have a same surface pattern for all the test groups.
  • 3. The cement materials were mixed according to the product instructions and applied onto the prepared, briefly dried tooth surface. The ceramic rod was then seated onto the cement surface under a 500 gram load with the aid of a BenCor Multi-test device (Danville Engineering, CA).
  • 4. After the cement hardened, the bonded samples were transferred into a 100% humidity chamber held at 37° C. for 24 hours before the debond test.
  • 5. The debond test was done in push shear mode using a BenCor testing device on an ATS testing machine. The load at which the bonded ceramic rod broke was recorded and the shear bonding strength of the testing sample was then calculated based on the rod surface area. Standard deviation is reported in parentheses.
    Shear Bonding Strength
    (the stress needed to break
    the bond between the 3G
    ceramic and the tooth
    Cement Materials surface), MPa (S.D.) Notes
    Cement material 12.2 (2.8) A paste-paste self-
    as in Example 6 adhesive resin cement
    Fleck's ® Zinc 0.5 (0.8) A powder-liquid
    Cement (A con- cement system as a
    ventional zinc control available
    phosphate cement from Mizzy, Inc.,
    for dental Cherry Hill, NJ.
    restorations)
    Lute-It! ™ resin 0.3 (1.2) A paste-paste conven-
    cement, shade A2 tional methacrylate
    resin cement as a
    control and used
    without a separated
    bonding procedure
    before the applica-
    tion of the cement
    available from Pen-
    tron Corp., Walling-
    ford, CT.
    Lute-It ™ resin 14.8 (1.6) Before apply the
    cement, shade A2, mixed cement onto
    used in conjunc- the tooth surface, a
    tion with Bond-1 ™ separated bonding
    dental adhesive procedure is per-
    formed per the in-
    struction of the
    Bond-1 ™ dental
    bonding system,
    available from
    Pentron Corp.,
    Wallingford, CT.
  • While the invention has been described with reference to exemplary embodiments, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular embodiment disclosed as the best mode contemplated for carrying out this invention, but that the invention will include all embodiments falling within the scope of the appended embodiments.

Claims (15)

1. A composition comprising a polymerizable (meth)acrylate of the structure:
Figure US20050192374A1-20050901-C00017
wherein
A is an anhydride;
a is 0 or 1;
n is 0, 1, 2, or 3;
R1, R2, R3, and R4 are each independently hydrogen, hydroxy, C1-C12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene);
x and y are each independently an integer of 1 to 10;
z is an integer of 1 to 5;
R5 is hydrogen or methyl;
Figure US20050192374A1-20050901-C00018
wherein G and J are each independently O or NR6, wherein R6 is hydrogen or C1-C6 alkyl;
m is 1, 2, 3, or 4;
W is an organic group having the valency of z+1; and
q is 0 or 1;
and further wherein when a is 1, n+m+q is 1, 2, 3, or 4, and when a is 0, n+m+q is 1, 2, 3, 4, 5, or 6.
2. The composition of claim 1, wherein R1, R2, R3, and R4 are each independently hydrogen or C1-C12 alkyl; and x and y are each independently an integer from 1 to 5.
3. The composition of claim 1, wherein a is 0; R1, R2, R3, and R4 are each independently hydrogen; x is 5; y is 2; and M is
Figure US20050192374A1-20050901-C00019
wherein G is oxygen.
4. The composition of claim 3, wherein n is 0, 1, or 2.
5. The composition of claim 1, having the structure:
Figure US20050192374A1-20050901-C00020
wherein
R6 and R7 are each independently hydrogen, hydroxy, C1-C 12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene);
z is an integer of 1 to 5.
6. The composition of claim 5, wherein z is 1 to 3, R1, R2, R3, R4, R6, and R7 are each independently hydrogen, hydroxy, or C1-C12 alkyl, and x and y are each independently an integer from 1 to 6.
7. The composition of claim 1, wherein the polymerizable (meth)acrylate is prepared by the reaction of an aromatic compound comprising anhydride functionality, carboxylic acid functionality, or a combination thereof; and a hydroxy-containing (meth)acrylate monomer of the structure:
Figure US20050192374A1-20050901-C00021
wherein
R1, R2, R3, and R4 are each independently hydrogen, hydroxy, C1-C12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene);
x and y are each independently an integer from 1 to 10;
R5 is hydrogen or methyl; and
Figure US20050192374A1-20050901-C00022
wherein G and J are each independently O or NR6, wherein R6 is hydrogen or C1-C6 alkyl.
8. The composition of claim 7, wherein the aromatic compound is benzenetetracarboxylic acid; benzenetetracarboxylic acid dianhydride; 1,3-dihydro-1,3-dioxoisobenzofuran-4,5-dicarboxylic acid; pyromellitic dianhydride; benzene-1,2,4,5-tetracarboxylic acid; 1,3-dihydro-1,3-dioxoisobenzofuran-5,6-dicarboxylic acid; trimellitic anhydride; trimellitic acid; terephthalic acid; phthalic acid; phthalic anhydride; benzoic acid; or a combination comprising at least one of the foregoing aromatics.
9. The composition of claim 7, further comprising reaction with a different hydroxy-containing (meth)acrylate of the structure:
Figure US20050192374A1-20050901-C00023
10. The composition of claim 7, further comprising reaction with a different hydroxy-containing (meth)acrylate of the structure:
Figure US20050192374A1-20050901-C00024
wherein R6 and R7 are each independently hydrogen, hydroxy, C1-C12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene); z is an integer from 1 to 10; and R5 is hydrogen or methyl.
11. The composition of claim 1, comprising
about 1 to about 90 weight percent of a filler system based on the total weight of the composition; and
a curing system.
12. The composition of claim 11, further comprising an additional ethylenically unsaturated monomer and/or oligomer that is co-curable with the polymerizable (meth)acrylate.
13. A method of manufacturing a composition, comprising:
reacting a hydroxy-containing (meth)acrylate monomer of the structure:
Figure US20050192374A1-20050901-C00025
wherein
R1, R2, R3, and R4 are each independently hydrogen, hydroxy, C1-C12 alkyl, C1-C12 perhaloalkyl, C1-C12 alkoxy, C1-C12 perhaloalkoxy, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C6 alkyl)-O-(C1-C6 alkylene), or hydroxy(C1-C6 alkylene);
x and y are each independently an integer from 1 to 10;
R5 is hydrogen or methyl; and
Figure US20050192374A1-20050901-C00026
wherein G and J are each independently O or NR6, wherein R6 is hydrogen or C1-C6 alkyl; with
an aromatic compound comprising anhydride functionality, carboxylic acid functionality, or a combination thereof, to form a polymerizable (meth)acrylate.
14. The method of claim 13, wherein the aromatic compound comprising anhydride or carboxylic acid functionality is further reacted with an additional hydroxy-containing (meth)acrylate.
15. A method of making a dental restoration, comprising
applying to a site to be restored a composition comprising
a curing agent; and
a polymerizable (meth)acrylate of claim 1; and
curing the composition to form a dental restoration.
US11/046,093 2004-01-29 2005-01-28 Dental resin composition, method of manufacture, and method of use thereof Active 2027-06-05 US7700667B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/046,093 US7700667B2 (en) 2004-01-29 2005-01-28 Dental resin composition, method of manufacture, and method of use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54014804P 2004-01-29 2004-01-29
US11/046,093 US7700667B2 (en) 2004-01-29 2005-01-28 Dental resin composition, method of manufacture, and method of use thereof

Publications (2)

Publication Number Publication Date
US20050192374A1 true US20050192374A1 (en) 2005-09-01
US7700667B2 US7700667B2 (en) 2010-04-20

Family

ID=34889741

Family Applications (1)

Application Number Title Priority Date Filing Date
US11/046,093 Active 2027-06-05 US7700667B2 (en) 2004-01-29 2005-01-28 Dental resin composition, method of manufacture, and method of use thereof

Country Status (1)

Country Link
US (1) US7700667B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060270752A1 (en) * 2005-05-26 2006-11-30 Ada Foundation Dental releasing materials
US20070049656A1 (en) * 2005-09-01 2007-03-01 Pentron Clinical Technologies, Inc Dental resin composition, method of manufacture, and method of use thereof
US20070197682A1 (en) * 2006-02-23 2007-08-23 Weitao Jia Self etch all purpose dental cement composition, method of manufacture, and method of use thereof
US20080242761A1 (en) * 2006-02-23 2008-10-02 Weitao Jia Self etch all purpose dental compositions, method of manufacture, and method of use thereof
US20080286724A1 (en) * 2007-05-18 2008-11-20 Ormco Corporation Orthodontic adhesives
EP2230286A1 (en) * 2009-03-20 2010-09-22 Pentron Clinical Technologies, LLC Dental resin composition, method of manufacture, and method uf use thereof
US20110171608A1 (en) * 2006-02-23 2011-07-14 Pentron Clinical Technologies, L.L.C. Self etch all purpose dental cement composition and method of use thereof
US8053490B2 (en) 2009-05-18 2011-11-08 Pentron Clinical Technologies, Llc Pre-treated acid-reactive fillers and their use in dental applications
US20160045403A1 (en) * 2013-03-15 2016-02-18 The Regents Of The University Of California Calcium sulfate-resin hybrid materials and methods of using and making the same

Citations (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3066112A (en) * 1959-01-30 1962-11-27 Rafael L Bowen Dental filling material comprising vinyl silane treated fused silica and a binder consisting of the reaction product of bis phenol and glycidyl acrylate
US3194784A (en) * 1959-01-30 1965-07-13 Rafael L Bowen Silica-resin direct filling material and method of preparation
US3926906A (en) * 1968-06-14 1975-12-16 Johnson & Johnson Dental filling package
US4148988A (en) * 1977-06-28 1979-04-10 Mitsui Petrochemical Industries Ltd. Curable composition
US4504635A (en) * 1982-11-02 1985-03-12 Union Carbide Corporation Process for the preparation of polymeric compositions
US4544359A (en) * 1984-01-13 1985-10-01 Pentron Corporation Dental restorative material
US4547531A (en) * 1984-08-02 1985-10-15 Pentron Corporation Two component (paste-paste) self-curing dental restorative material
US4659751A (en) * 1983-01-10 1987-04-21 American Dental Association Health Foundation Simplified method for obtained strong adhesive bonding of composites to dentin, enamel and other substrates
US4691045A (en) * 1984-12-06 1987-09-01 Nippon Shokubai Kagaku Co., Ltd. Hydroxyl group-containing (meth)acrylate oligomer, prepolymer therefrom, and method for use thereof
US4732943A (en) * 1985-04-24 1988-03-22 Commonwealth Scientific And Industrial Research Organization Dental restorative material
US4786749A (en) * 1986-02-20 1988-11-22 Union Carbide Corporation Carboxyl-terminated lactone acrylates
US4883899A (en) * 1986-01-08 1989-11-28 Nippon Paint Co., Ltd. End carboxyl bearing reactive vinyl monomers and preparation thereof
US5171763A (en) * 1990-12-14 1992-12-15 Tokuyama Soda Kabushiki Kaisha Curable composition
US5260476A (en) * 1990-12-14 1993-11-09 Tokuyama Soda Kabushiki Kaisha Diacrylate compounds
US5264513A (en) * 1990-02-15 1993-11-23 Kabushiki Kaisha Shofu Primer composition
US5276068A (en) * 1985-03-29 1994-01-04 Jeneric/Pentron, Inc. Dental resin materials
US5348988A (en) * 1990-04-12 1994-09-20 Bisco, Inc. Dentin bonding system
US5525648A (en) * 1991-12-31 1996-06-11 Minnesota Mining And Manufacturing Company Method for adhering to hard tissue
US5756560A (en) * 1994-02-01 1998-05-26 The United States Of America As Represented By The Secretary Of The Commerce Method and composition for promoting improved adhesion to substrates
US5925690A (en) * 1995-11-20 1999-07-20 Tokuyama Corproation Dental primer composition and kit
US5969000A (en) * 1997-01-17 1999-10-19 Jeneric Pentron Incorporated Dental resin materials
US6013694A (en) * 1997-10-16 2000-01-11 Jeneric/Pentron Incorporated Dental composites comprising ground, densified, embrittled glass fiber filler
US6071983A (en) * 1993-08-02 2000-06-06 Sun Medical Co., Ltd. Primer composition and curable composition
US6147137A (en) * 1998-09-10 2000-11-14 Jeneric/Pentron Incorporated Dental primer and adhesive
US6217644B1 (en) * 1998-08-09 2001-04-17 Gc Corporation Dental adhesive set
US6291548B1 (en) * 1998-08-11 2001-09-18 Gc Corporation Dental cement composition
US6326417B1 (en) * 1999-10-21 2001-12-04 Jeneric/Pentron Incorporated Anti-microbial dental compositions and method
US20020045678A1 (en) * 2000-08-22 2002-04-18 Lopez Larry A. Dental restorative compositions and method of use thereof
US20020082317A1 (en) * 1998-09-11 2002-06-27 Sultan Chemists, Inc. Dental adhesive compositions with desensitizing agents
US20020120033A1 (en) * 2000-08-11 2002-08-29 Weitao Jia Dental/medical compositions comprising degradable polymers and methods of manufacture thereof
US20030055124A1 (en) * 2001-08-10 2003-03-20 Klee Joachim E. Hydrolysis stable one-part self-etching, self-priming dental adhesive
US20030125444A1 (en) * 2001-11-02 2003-07-03 Weitao Jia Dental resin materials, method of manufacture, and uses thereof
US20030175659A1 (en) * 2002-02-07 2003-09-18 Amer Tiba Multifunctional dentin bonding agent
US20030207960A1 (en) * 2001-05-10 2003-11-06 Weitao Jia Self-etching primer adhesive and method of use therefor
US6649669B2 (en) * 2001-12-28 2003-11-18 American Dental Association Health Foundation Single solution bonding formulation
US6653365B2 (en) * 2001-05-01 2003-11-25 Pentron Clinical Technologies, Llc Dental composite materials and method of manufacture thereof
US6759449B2 (en) * 2000-11-28 2004-07-06 Tokuyama Dental Corporation Dental adhesive composition
US20040156795A1 (en) * 2001-07-09 2004-08-12 Kimiya Nemoto Dental self-etching primer
US6815470B2 (en) * 2000-09-26 2004-11-09 Tokuyama Corporation Dental catalyst for chemical polymerization and use thereof
US20040229973A1 (en) * 2003-05-13 2004-11-18 Junjie Sang Dental adhesive compositions and methods
US20040235981A1 (en) * 2003-05-19 2004-11-25 Kerr Corporation Two-part self-adhering dental compositions
US20050014861A1 (en) * 2003-07-17 2005-01-20 Kerr Corporations Methods of using two-part self-adhering dental compositions
US20050020720A1 (en) * 2003-07-02 2005-01-27 Ada Foundation Remineralizing dental cements
US20050038135A1 (en) * 2001-05-01 2005-02-17 Shuhua Jin Dental composite materials and method of manufacture thereof
US20050049326A1 (en) * 2003-08-29 2005-03-03 Park Kwang Soo Dental self-curing resin cement compositions
US6939900B2 (en) * 1997-07-17 2005-09-06 3M Innovative Properties Company Dental resin cements having improved handling properties
US20050277706A1 (en) * 2004-06-09 2005-12-15 Han Dong K Highly functional dental adhesive composition
US20070197683A1 (en) * 2006-02-23 2007-08-23 Pentron Clinical Technologies, Inc Self etch all purpose dental compositions, method of manufacture, and method of use thereof
US20080242761A1 (en) * 2006-02-23 2008-10-02 Weitao Jia Self etch all purpose dental compositions, method of manufacture, and method of use thereof

Patent Citations (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194784A (en) * 1959-01-30 1965-07-13 Rafael L Bowen Silica-resin direct filling material and method of preparation
US3066112A (en) * 1959-01-30 1962-11-27 Rafael L Bowen Dental filling material comprising vinyl silane treated fused silica and a binder consisting of the reaction product of bis phenol and glycidyl acrylate
US3926906A (en) * 1968-06-14 1975-12-16 Johnson & Johnson Dental filling package
US4148988A (en) * 1977-06-28 1979-04-10 Mitsui Petrochemical Industries Ltd. Curable composition
US4504635A (en) * 1982-11-02 1985-03-12 Union Carbide Corporation Process for the preparation of polymeric compositions
US4659751A (en) * 1983-01-10 1987-04-21 American Dental Association Health Foundation Simplified method for obtained strong adhesive bonding of composites to dentin, enamel and other substrates
US4544359A (en) * 1984-01-13 1985-10-01 Pentron Corporation Dental restorative material
US4547531A (en) * 1984-08-02 1985-10-15 Pentron Corporation Two component (paste-paste) self-curing dental restorative material
US4691045A (en) * 1984-12-06 1987-09-01 Nippon Shokubai Kagaku Co., Ltd. Hydroxyl group-containing (meth)acrylate oligomer, prepolymer therefrom, and method for use thereof
US5276068A (en) * 1985-03-29 1994-01-04 Jeneric/Pentron, Inc. Dental resin materials
US4732943A (en) * 1985-04-24 1988-03-22 Commonwealth Scientific And Industrial Research Organization Dental restorative material
US4883899A (en) * 1986-01-08 1989-11-28 Nippon Paint Co., Ltd. End carboxyl bearing reactive vinyl monomers and preparation thereof
US4786749A (en) * 1986-02-20 1988-11-22 Union Carbide Corporation Carboxyl-terminated lactone acrylates
US5264513A (en) * 1990-02-15 1993-11-23 Kabushiki Kaisha Shofu Primer composition
US5348988A (en) * 1990-04-12 1994-09-20 Bisco, Inc. Dentin bonding system
US5260476A (en) * 1990-12-14 1993-11-09 Tokuyama Soda Kabushiki Kaisha Diacrylate compounds
US5171763A (en) * 1990-12-14 1992-12-15 Tokuyama Soda Kabushiki Kaisha Curable composition
US5525648A (en) * 1991-12-31 1996-06-11 Minnesota Mining And Manufacturing Company Method for adhering to hard tissue
US6071983A (en) * 1993-08-02 2000-06-06 Sun Medical Co., Ltd. Primer composition and curable composition
US5756560A (en) * 1994-02-01 1998-05-26 The United States Of America As Represented By The Secretary Of The Commerce Method and composition for promoting improved adhesion to substrates
US5925690A (en) * 1995-11-20 1999-07-20 Tokuyama Corproation Dental primer composition and kit
US5969000A (en) * 1997-01-17 1999-10-19 Jeneric Pentron Incorporated Dental resin materials
US6939900B2 (en) * 1997-07-17 2005-09-06 3M Innovative Properties Company Dental resin cements having improved handling properties
US6013694A (en) * 1997-10-16 2000-01-11 Jeneric/Pentron Incorporated Dental composites comprising ground, densified, embrittled glass fiber filler
US6217644B1 (en) * 1998-08-09 2001-04-17 Gc Corporation Dental adhesive set
US6291548B1 (en) * 1998-08-11 2001-09-18 Gc Corporation Dental cement composition
US6147137A (en) * 1998-09-10 2000-11-14 Jeneric/Pentron Incorporated Dental primer and adhesive
US20040054027A1 (en) * 1998-09-11 2004-03-18 Sultan Chemists, Inc. Dental adhesive compositions with desensitizing agents
US20020082317A1 (en) * 1998-09-11 2002-06-27 Sultan Chemists, Inc. Dental adhesive compositions with desensitizing agents
US6326417B1 (en) * 1999-10-21 2001-12-04 Jeneric/Pentron Incorporated Anti-microbial dental compositions and method
US20020120033A1 (en) * 2000-08-11 2002-08-29 Weitao Jia Dental/medical compositions comprising degradable polymers and methods of manufacture thereof
US20020045678A1 (en) * 2000-08-22 2002-04-18 Lopez Larry A. Dental restorative compositions and method of use thereof
US6815470B2 (en) * 2000-09-26 2004-11-09 Tokuyama Corporation Dental catalyst for chemical polymerization and use thereof
US6759449B2 (en) * 2000-11-28 2004-07-06 Tokuyama Dental Corporation Dental adhesive composition
US6653365B2 (en) * 2001-05-01 2003-11-25 Pentron Clinical Technologies, Llc Dental composite materials and method of manufacture thereof
US20050038135A1 (en) * 2001-05-01 2005-02-17 Shuhua Jin Dental composite materials and method of manufacture thereof
US20030207960A1 (en) * 2001-05-10 2003-11-06 Weitao Jia Self-etching primer adhesive and method of use therefor
US20040156795A1 (en) * 2001-07-09 2004-08-12 Kimiya Nemoto Dental self-etching primer
US20030055124A1 (en) * 2001-08-10 2003-03-20 Klee Joachim E. Hydrolysis stable one-part self-etching, self-priming dental adhesive
US20030125444A1 (en) * 2001-11-02 2003-07-03 Weitao Jia Dental resin materials, method of manufacture, and uses thereof
US6649669B2 (en) * 2001-12-28 2003-11-18 American Dental Association Health Foundation Single solution bonding formulation
US20030175659A1 (en) * 2002-02-07 2003-09-18 Amer Tiba Multifunctional dentin bonding agent
US6673958B2 (en) * 2002-02-07 2004-01-06 Bisco, Inc. Multifunctional dentin bonding agent
US20070299157A1 (en) * 2003-05-13 2007-12-27 Junjie Sang Dental adhesive compositions and methods
US20040229973A1 (en) * 2003-05-13 2004-11-18 Junjie Sang Dental adhesive compositions and methods
US20040235981A1 (en) * 2003-05-19 2004-11-25 Kerr Corporation Two-part self-adhering dental compositions
US20050020720A1 (en) * 2003-07-02 2005-01-27 Ada Foundation Remineralizing dental cements
US20050014861A1 (en) * 2003-07-17 2005-01-20 Kerr Corporations Methods of using two-part self-adhering dental compositions
US20050049326A1 (en) * 2003-08-29 2005-03-03 Park Kwang Soo Dental self-curing resin cement compositions
US20050277706A1 (en) * 2004-06-09 2005-12-15 Han Dong K Highly functional dental adhesive composition
US20070197683A1 (en) * 2006-02-23 2007-08-23 Pentron Clinical Technologies, Inc Self etch all purpose dental compositions, method of manufacture, and method of use thereof
US20070197682A1 (en) * 2006-02-23 2007-08-23 Weitao Jia Self etch all purpose dental cement composition, method of manufacture, and method of use thereof
US20080242761A1 (en) * 2006-02-23 2008-10-02 Weitao Jia Self etch all purpose dental compositions, method of manufacture, and method of use thereof

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060270752A1 (en) * 2005-05-26 2006-11-30 Ada Foundation Dental releasing materials
US20070049656A1 (en) * 2005-09-01 2007-03-01 Pentron Clinical Technologies, Inc Dental resin composition, method of manufacture, and method of use thereof
US7855242B2 (en) 2005-09-01 2010-12-21 Pentron Clinical Technologies Llc Dental resin composition, method of manufacture, and method of use thereof
WO2007100569A2 (en) * 2006-02-23 2007-09-07 Pentron Clinical Technologies Llc Self etch all purpose dental composition
US8664294B2 (en) 2006-02-23 2014-03-04 Pentron Clinical Technologies, Llc Self etch all purpose dental cement composition and method of use thereof
WO2007100569A3 (en) * 2006-02-23 2008-05-22 Pentron Clinical Technologies Self etch all purpose dental composition
US20080242761A1 (en) * 2006-02-23 2008-10-02 Weitao Jia Self etch all purpose dental compositions, method of manufacture, and method of use thereof
JP2009527561A (en) * 2006-02-23 2009-07-30 ペントロン クリニカル テクノロジーズ リミテッド ライアビリティ カンパニー Self-etching universal dental composition, method for producing the same, and method for using the same
US20070197683A1 (en) * 2006-02-23 2007-08-23 Pentron Clinical Technologies, Inc Self etch all purpose dental compositions, method of manufacture, and method of use thereof
US20070197682A1 (en) * 2006-02-23 2007-08-23 Weitao Jia Self etch all purpose dental cement composition, method of manufacture, and method of use thereof
US7906564B2 (en) 2006-02-23 2011-03-15 Pentron Clinical Technologies, Llc Self etch all purpose dental cement composition, method of manufacture, and method of use thereof
US20110171608A1 (en) * 2006-02-23 2011-07-14 Pentron Clinical Technologies, L.L.C. Self etch all purpose dental cement composition and method of use thereof
US20080286724A1 (en) * 2007-05-18 2008-11-20 Ormco Corporation Orthodontic adhesives
US9408782B2 (en) 2007-05-18 2016-08-09 Ormco Corporation Orthodontic adhesives
EP1992321A3 (en) * 2007-05-18 2010-10-13 Ormco Corporation Orthodontic adhesives
US8821157B2 (en) 2007-05-18 2014-09-02 Ormco Corporation Orthodontic adhesives
US20100240794A1 (en) * 2009-03-20 2010-09-23 Shuhua Jin Dental resin composition, method of manufacture, and method of use thereof
US8163815B2 (en) 2009-03-20 2012-04-24 Pentron Clinical Technologies, Llc Dental resin composition, method of manufacture, and method of use thereof
EP2230286A1 (en) * 2009-03-20 2010-09-22 Pentron Clinical Technologies, LLC Dental resin composition, method of manufacture, and method uf use thereof
US8053490B2 (en) 2009-05-18 2011-11-08 Pentron Clinical Technologies, Llc Pre-treated acid-reactive fillers and their use in dental applications
US20160045403A1 (en) * 2013-03-15 2016-02-18 The Regents Of The University Of California Calcium sulfate-resin hybrid materials and methods of using and making the same
US9889071B2 (en) * 2013-03-15 2018-02-13 The Regents Of The University Of California Calcium sulfate-resin hybrid materials and methods of using and making the same

Also Published As

Publication number Publication date
US7700667B2 (en) 2010-04-20

Similar Documents

Publication Publication Date Title
US7632877B2 (en) Dental resins, dental composite materials, and method of manufacture thereof
US7700667B2 (en) Dental resin composition, method of manufacture, and method of use thereof
US6653365B2 (en) Dental composite materials and method of manufacture thereof
US7906564B2 (en) Self etch all purpose dental cement composition, method of manufacture, and method of use thereof
US6730715B2 (en) Dental restorative composition, dental restoration, and a method of use thereof
US7855242B2 (en) Dental resin composition, method of manufacture, and method of use thereof
US7470728B2 (en) Dental glazes and method of manufacture and use thereof
US7589132B2 (en) Dental resins, dental composite materials, and method of manufacture thereof
US20020045678A1 (en) Dental restorative compositions and method of use thereof
JP4986437B2 (en) Dental curable composition
US7160941B2 (en) Dental composite materials and method of manufacture thereof
US20050124762A1 (en) Dental compositions containing core-shell polymers with low modulus cores
JP4425568B2 (en) Dental composition
US20080242761A1 (en) Self etch all purpose dental compositions, method of manufacture, and method of use thereof
US6767955B2 (en) Flowable dental resin materials and method of use thereof
US8163815B2 (en) Dental resin composition, method of manufacture, and method of use thereof
US20130023600A1 (en) Dental compositions containing short-cut fibers
US4420306A (en) Tetraacrylic and tetramethacrylic esters and dental materials containing same
WO2002015848A2 (en) Dental restorative compositions and method of use thereof
US8664294B2 (en) Self etch all purpose dental cement composition and method of use thereof
US20050124722A1 (en) Branched highly-functional monomers exhibiting low polymerization shrinkage
JP3409291B2 (en) Amine-based unsaturated compound and photocurable composition containing the same
US20070015845A1 (en) Dental resin composition, method of manufacture, and method of use thereof
WO2023042715A1 (en) (meth)acrylamide compound, monomer composition, composition for dental material, and dental material
JP2023095695A (en) dental adhesive kit

Legal Events

Date Code Title Description
AS Assignment

Owner name: PENTRON CLINICAL TECHNOLOGIES, LLC,CONNECTICUT

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JIN, SHUHUA;JIA, WEITAO;REEL/FRAME:016320/0855

Effective date: 20050526

Owner name: PENTRON CLINICAL TECHNOLOGIES, LLC, CONNECTICUT

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JIN, SHUHUA;JIA, WEITAO;REEL/FRAME:016320/0855

Effective date: 20050526

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552)

Year of fee payment: 8

AS Assignment

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, NORTH CAROLINA

Free format text: SECURITY INTEREST;ASSIGNOR:KERR CORPORATION;REEL/FRAME:052611/0362

Effective date: 20200506

AS Assignment

Owner name: KERR CORPORATION, CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:055886/0185

Effective date: 20210408

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12